✦ LIBER ✦

Luteinizing hormone-releasing hormone analogues and hormone ablation for prostate cancer: state of the art

✍ Scribed by Andrew V. Schally

Book ID: 109053313
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 60 KB
Volume: 100
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2007.06942.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemohormonal therapy as primary treatme

Chemohormonal therapy as primary treatment for metastatic prostate cancer: A randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist

✍ MASANORI NOGUCHI; SHINSHI NODA; MASAKI YOSHIDA; SHOICHI UEDA; TAIZO SHIRAISHI; K 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Combination of somatostatin analogues an

Combination of somatostatin analogues and dexamethasone (antisurvival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis

✍ Michael Koutsilieris; Theodore Dimopoulos; Constantine Milathianakis; John Bogda 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Roles of the urologist and nurse from th

Roles of the urologist and nurse from the perspective of patients with prostate cancer receiving luteinizing hormone-releasing hormone analogue therapy

✍ Thierry Lebret; Alain Bouregba 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Auricular acupuncture: a novel treatment

Auricular acupuncture: a novel treatment for vasomotor symptoms associated with luteinizing-hormone releasing hormone agonist treatment for prostate cancer

✍ Christopher Harding; Andrea Harris; David Chadwick 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Bone fractures associated with luteinizi

Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma

✍ Murphy F. Townsend; W. Holt Sanders; Robert O. Northway; Sam D. Graham Jr. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

## Background: Luteinizing hormone-releasing hormone agonists (lhrh-a) have become an established treatment for certain patients with prostate carcinoma. lhrh-a are known to decrease bone mineral density. the purpose of this study was to determine the risk of bone fracture in men receiving lhrh-a f

Antagonists of bombesin/gastrin-releasin

Antagonists of bombesin/gastrin-releasing peptide as adjuncts to agonists of luteinizing hormone–releasing hormone in the treatment of experimental prostate cancer

✍ Jacek Pinski; Gabor Halmos; Karoly Szepeshazi; Andrew V. Schally 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 752 KB